The development of liposome formulations is crucial in the design and delivery of drugs, as they can enhance drug efficacy, improve bioavailability, and minimize side effects. CD Formulation is a leading global pharmaceutical technology company committed to developing cutting-edge targeted liposome systems for various delivery routes and different active substances through our team of experts skilled in designing and manufacturing such systems. The significance of liposome research and application in modern medicine drives our unwavering commitment to advancing the development of liposome technology. We aim to harness the potential of our technology and services, offering expanded possibilities across various fields. Through continuous innovation and breakthroughs, we strive to optimize liposome technology's contribution towards human health and well-being.
The process of developing liposome formulations is intricate and iterative, requiring a profound understanding of the physicochemical properties of liposomes and their interactions with cells and tissues. One key advantage of liposomes lies in their ability to encapsulate both hydrophilic and hydrophobic drugs, enabling the co-delivery of multiple agents within a single formulation. This capability can significantly enhance combination therapies' effectiveness while reducing the need for multiple injections, thereby improving patient compliance. Moreover, by utilizing ligands or nanoparticles, liposomes can be targeted toward specific cells or tissues for site-specific drug delivery. This targeted approach not only reduces systemic toxicity but also enhances the therapeutic window for drugs. The development of liposome formulations holds immense significance in the realm of human health. In medicine, it is anticipated to assume a pivotal role in the treatment and prevention of various diseases; concurrently, it finds extensive application in the domains of cosmetics and nutritional supplements.
We possess unique liposome formulation technology, which can produce various types of liposomes, including single-chamber liposomes, multi-chamber liposomes and nano-liposomes. Our team of experts provides comprehensive services for the development of liposome formulations. With years of experience and in-depth knowledge in the field, we can assist you in every step of the process, from initial concept to final product.
Our services include, but are not limited to:
Our service platform effectively addresses the common challenges associated with oral liposomes, including gastrointestinal instability, difficulties in biofilm penetration, and batch production issues. Additionally, we minimize food interference and individual differences to ensure high-quality and efficient oral liposome formulations that cater to diverse industries and application scenarios.
In addition to conventional liposomes, our team has developed a range of deformable liposomal formulations, including ethosomes (such as propylene glycol-based liposomes), transethosomes, and niosomes. We are dedicated to delivering exceptional transdermal liposomal products that meet the highest standards.
Our nebulizer liposome development platform incorporates cutting-edge nebulizer and inhaler technologies, enabling us to create a diverse range of liposomal nebulizers, including aqueous solutions and dry powders.
We are dedicated to advancing the field of injectable liposomes by harnessing state-of-the-art technologies, including degradable and injectable polymer liposome hydrogels, PEG-modified liposomes, and environmentally responsive liposomes.
Our lyophilized technology for liposome formulations mitigates stability risks and enhances the shelf life of liposomal formulations. Presently, our freeze-drying technique applies to various administration routes, including parenteral, oral, nasal, and/or pulmonary delivery.
We are dedicated to fostering innovation and harnessing state-of-the-art technology to explore the potential of next-generation liposome delivery systems in ophthalmic formulations.
Fig.1 The Workflow of Liposome Formulation Development. (CD Formulation)
Liposome Preparation Techniques | Solvent injection method, film hydration method, reverse evaporation method, double emulsion method, and microfluidic method. |
Drug Loading Techniques | Active drug loading technology (ammonium sulfate gradient method, or later adopted pH gradient method, sucrose octasulfate ion gradient method, copper gluconate ion gradient method, calcium acetate ion gradient method, etc.) and passive drug loading technology. |
Liposome Delivery Techniques | Environmentally responsive liposome delivery technology, long-cycle liposome delivery technology, deformable liposome delivery technology, membrane fusion liposome delivery technology, immune liposome delivery technology, single compartment liposome delivery technology, multi-layer liposome delivery technology, multi-capsule liposome delivery technology, etc. |
Liposomes are extensively utilized in the treatment of major diseases, cosmetics, vaccines, and nutritional supplements. Applications in the field of medicine, for instance:
Tumor |
|
Anti-inflammatory and anti-infective drugs |
|
Eye diseases |
|
Neurodegenerative diseases |
|
Antimalarial drugs |
|
The CD Formulation team comprises a group of dedicated research scientists who are determined to overcome any challenges that may arise during the development of liposomes. Please do not hesitate to contact us for assistance.